Javier García del Pozo-rekin lankidetzan egindako argitalpenak (10)

2010

  1. Response to rupatadine and heart rhythm disturbances

    Clinical Pharmacology and Therapeutics

2009

  1. Evolución del consumo de psicofármacos en Castilla y León durante el período 1992-2005

    Anales de la Real Academia de Medicina y Cirugía de Valladolid, Núm. 46, pp. 161-175

  2. Heart rhythm disturbances associated with rupatadine: A case series from the Spanish and Portuguese pharmacovigilance systems

    Clinical Pharmacology and Therapeutics, Vol. 85, Núm. 5, pp. 481-484

2006

  1. Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: Analysis from national spontaneous reporting systems

    Fundamental and Clinical Pharmacology, Vol. 20, Núm. 4, pp. 391-395

2004

  1. Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study

    European Journal of Clinical Pharmacology, Vol. 60, Núm. 6, pp. 439-444

2000

  1. Withdrawal syndrome after long-term treatment with tramadol

    British Journal of General Practice

1999

  1. El consumo de analgesicos opiaceos en Espana. El papel de la codeina

    Medicina Clinica

  2. El ensayo clinico no garantiza la seguridad de los medicamentos. A proposito del caso de la fenfluramina y dexfenfluramina

    Medicina Clinica

  3. Opioid consumption in Spain - The significance of a regulatory measure

    European Journal of Clinical Pharmacology, Vol. 55, Núm. 9, pp. 681-683

1997

  1. Cambios en el patron de consumo de analgesicos opioides en Espana

    Medicina Clinica, Vol. 109, Núm. 8, pp. 281-283